Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Baraclude
Active Ingredient: Entecavir 0.05mg/mL
Dosage Form: Oral solution
New Zealand Sponsor: Bristol-Myers Squibb (NZ) Company
Manufacturer: Bristol-Myers Squibb Company, Mt Vernon Plant, Indiana, United States of America
Product: Baraclude
Active Ingredient: Entecavir 0.5mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Bristol-Myers Squibb (NZ) Company
Manufacturer: Bristol-Myers Squibb Company, Mt Vernon Plant, Indiana, United States of America
Product: Baraclude
Active Ingredient: Entecavir 1mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Bristol-Myers Squibb (NZ) Company
Manufacturer: Bristol-Myers Squibb Company, Mt Vernon Plant, Indiana, United States of America
Product: Brimonidine-AFT
Active Ingredient: Brimonidine tartrate 2mg/mL
Dosage Form: Eye drops, solution
New Zealand Sponsor: AFT Pharmaceuticals Limited
Manufacturer: Sterigen Inc, Upton, Quebec, Canada
Product: Carboplatin Ebewe
Active Ingredient: Carboplatin 10mg/mL
Dosage Form: Concentrate for injection
New Zealand Sponsor: Pharmaco (NZ) Limited
Manufacturer: EBEWE Pharma GmbH Nfg KG, Unterach am Attersee, Austria
Product: Octreotide
Active Ingredient: Octreotide acetate 0.05mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Mayne Pharma Limited
Manufacturer: Omega Laboratories, Montreal, Quebec, Canada
Product: Octreotide
Active Ingredient: Octreotide acetate 0.1mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Mayne Pharma Limited
Manufacturer: Omega Laboratories, Montreal, Quebec, Canada
Product: Octreotide
Active Ingredient: Octreotide acetate 0.5mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Mayne Pharma Limited
Manufacturer: Omega Laboratories, Montreal, Quebec, Canada
Dated this 15th day of September 2006.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).